276 related articles for article (PubMed ID: 27059596)
41. Bone marrow-derived dendritic cells can process bacteria for MHC-I and MHC-II presentation to T cells.
Svensson M; Stockinger B; Wick MJ
J Immunol; 1997 May; 158(9):4229-36. PubMed ID: 9126984
[TBL] [Abstract][Full Text] [Related]
42. Follicular helper NKT cells induce limited B cell responses and germinal center formation in the absence of CD4(+) T cell help.
Tonti E; Fedeli M; Napolitano A; Iannacone M; von Andrian UH; Guidotti LG; Abrignani S; Casorati G; Dellabona P
J Immunol; 2012 Apr; 188(7):3217-22. PubMed ID: 22379027
[TBL] [Abstract][Full Text] [Related]
43. Sublingual 'oral tolerance' induction with antigen conjugated to cholera toxin B subunit generates regulatory T cells that induce apoptosis and depletion of effector T cells.
Sun JB; Czerkinsky C; Holmgren J
Scand J Immunol; 2007; 66(2-3):278-86. PubMed ID: 17635805
[TBL] [Abstract][Full Text] [Related]
44. Immortalized dendritic cell line with efficient cross-priming ability established from transgenic mice harboring the temperature-sensitive SV40 large T-antigen gene.
Ebihara S; Endo S; Ito K; Ito Y; Akiyama K; Obinata M; Takai T
J Biochem; 2004 Sep; 136(3):321-8. PubMed ID: 15598888
[TBL] [Abstract][Full Text] [Related]
45. Human dendritic cells very efficiently present a heterologous antigen expressed on the surface of recombinant gram-positive bacteria to CD4+ T lymphocytes.
Corinti S; Medaglini D; Cavani A; Rescigno M; Pozzi G; Ricciardi-Castagnoli P; Girolomoni G
J Immunol; 1999 Sep; 163(6):3029-36. PubMed ID: 10477566
[TBL] [Abstract][Full Text] [Related]
46. In-vivo impaired T helper 1 cell development in submandibular lymph nodes due to IL-12 deficiency following antigen injection into the anterior chamber of the eye.
Perez VL; Biuckians AJ; Streilein JW
Ocul Immunol Inflamm; 2000 Mar; 8(1):9-24. PubMed ID: 10806431
[TBL] [Abstract][Full Text] [Related]
47. Genetically engineered fibroblasts with antigen-presenting capability: efficient induction of an antigen-specific cytotoxic T-lymphocyte response and protection against tumor development in vivo.
Kim TS; Chung SW; Kim SH; Kang BY; Hwang SY; Lee JW
Cancer Gene Ther; 2000 Jun; 7(6):861-9. PubMed ID: 10880016
[TBL] [Abstract][Full Text] [Related]
48. Immunization with a lentiviral vector stimulates both CD4 and CD8 T cell responses to an ovalbumin transgene.
Rowe HM; Lopes L; Ikeda Y; Bailey R; Barde I; Zenke M; Chain BM; Collins MK
Mol Ther; 2006 Feb; 13(2):310-9. PubMed ID: 16275163
[TBL] [Abstract][Full Text] [Related]
49. The nature of an in vivo anti-capsular polysaccharide response is markedly influenced by the composition and/or architecture of the bacterial subcapsular domain.
Arjunaraja S; Massari P; Wetzler LM; Lees A; Colino J; Snapper CM
J Immunol; 2012 Jan; 188(2):569-77. PubMed ID: 22156342
[TBL] [Abstract][Full Text] [Related]
50. The Vacuolar Pathway in Macrophages Plays a Major Role in Antigen Cross-Presentation Induced by the Pore-Forming Protein Sticholysin II Encapsulated Into Liposomes.
Cruz-Leal Y; Grubaugh D; Nogueira CV; Lopetegui-González I; Del Valle A; Escalona F; Laborde RJ; Alvarez C; Fernández LE; Starnbach MN; Higgins DE; Lanio ME
Front Immunol; 2018; 9():2473. PubMed ID: 30455685
[TBL] [Abstract][Full Text] [Related]
51. CD11c(high )dendritic cells are essential for activation of CD4+ T cells and generation of specific antibodies following mucosal immunization.
Fahlén-Yrlid L; Gustafsson T; Westlund J; Holmberg A; Strömbeck A; Blomquist M; MacPherson GG; Holmgren J; Yrlid U
J Immunol; 2009 Oct; 183(8):5032-41. PubMed ID: 19786541
[TBL] [Abstract][Full Text] [Related]
52. Hepatitis B virus surface antigen can activate dendritic cells and modulate T helper type immune response.
Jan RH; Lin YL; Chen LK; Huang MT; Wang LC; Chiang BL
Microbiol Immunol; 2011 Jan; 55(1):51-9. PubMed ID: 21175774
[TBL] [Abstract][Full Text] [Related]
53. Intranasal treatment with ovalbumin but not the major T cell epitope ovalbumin 323-339 generates interleukin-10 secreting T cells and results in the induction of allergen systemic tolerance.
Barbey C; Donatelli-Dufour N; Batard P; Corradin G; Spertini F
Clin Exp Allergy; 2004 Apr; 34(4):654-62. PubMed ID: 15080822
[TBL] [Abstract][Full Text] [Related]
54. Effective induction of anti-tumor immune responses with oligomannose-coated liposome targeting to intraperitoneal phagocytic cells.
Ikehara Y; Shiuchi N; Kabata-Ikehara S; Nakanishi H; Yokoyama N; Takagi H; Nagata T; Koide Y; Kuzushima K; Takahashi T; Tsujimura K; Kojima N
Cancer Lett; 2008 Feb; 260(1-2):137-45. PubMed ID: 18077084
[TBL] [Abstract][Full Text] [Related]
55. Marginal zone B cells transport IgG3-immune complexes to splenic follicles.
Zhang L; Ding Z; Xu H; Heyman B
J Immunol; 2014 Aug; 193(4):1681-9. PubMed ID: 25015822
[TBL] [Abstract][Full Text] [Related]
56. Ex vivo activated OVA specific and non-specific CD4+CD25+ regulatory T cells exhibit comparable suppression to OVA mediated T cell responses.
Li J; Bracht M; Shang X; Radewonuk J; Emmell E; Griswold DE; Li L
Cell Immunol; 2006 Jun; 241(2):75-84. PubMed ID: 17010326
[TBL] [Abstract][Full Text] [Related]
57. Dendritic cells pulsed with intact Streptococcus pneumoniae elicit both protein- and polysaccharide-specific immunoglobulin isotype responses in vivo through distinct mechanisms.
Colino J; Shen Y; Snapper CM
J Exp Med; 2002 Jan; 195(1):1-13. PubMed ID: 11781360
[TBL] [Abstract][Full Text] [Related]
58. The subcellular location of antigen expressed by adenoviral vectors modifies adaptive immunity but not dependency on cross-presenting dendritic cells.
Henning P; Gustafsson T; Flach CF; Hua YJ; Strömbeck A; Holmgren J; Lindholm L; Yrlid U
Eur J Immunol; 2011 Aug; 41(8):2185-96. PubMed ID: 21538977
[TBL] [Abstract][Full Text] [Related]
59. Follicular dendritic cells and the maintenance of IgE responses.
Helm SL; Burton GF; Szakal AK; Tew JG
Eur J Immunol; 1995 Aug; 25(8):2362-9. PubMed ID: 7664798
[TBL] [Abstract][Full Text] [Related]
60. Cytosolic Delivery of Liposomal Vaccines by Means of the Concomitant Photosensitization of Phagosomes.
Hjálmsdóttir Á; Bühler C; Vonwil V; Roveri M; Håkerud M; Wäckerle-Men Y; Gander B; Johansen P
Mol Pharm; 2016 Feb; 13(2):320-9. PubMed ID: 26704885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
